Sensipar

(cinacalcet) tablets

Overview Structured Data Issues Contributors

sensipar.com

Is a

Product

Product attributes

Industry

Pharmaceutical industry

Product Parent Company

Amgen

Sensipar® (cinacalcet) is indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis.

Sensipar® should not be used in patients with CKD who are not on dialysis because of an increased risk of low calcium levels.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like Sensipar

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API